Ana M. Ortiz
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 13
- Systemic Lupus Erythematosus Research 6
- Virology top 10%
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 6
- Family Practice top 10%
- Neurology top 10%
- Peripheral Neuropathies and Disorders 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Alzheimer's disease research and treatments 3
-
- Dialysis and Renal Disease Management 2
-
- Pharmaceutical studies and practices 2
- Co-authors
- Juan I. JorqueraIsidoro González‐ÁlvaroMontserrat CostaLoreto CarmonaJuan J. Gómez‐ReinoRosario García‐VicuñaAlejandro BalsaA Laffón
- Cited by
- RheumatologyVirologyHematology
- Partner nations
- SpainChileUnited States
In The Last Decade
Ana M. Ortiz
42 papers receiving 810 citations
Peers
Comparison fields: 5 of 97
- Rheumatology 275
- Virology 48
- Hematology 105
- Family Practice 18
- Neurology 111
Countries citing papers authored by Ana M. Ortiz
This map shows the geographic impact of Ana M. Ortiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. Ortiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. Ortiz more than expected).
Fields of papers citing papers by Ana M. Ortiz
This network shows the impact of papers produced by Ana M. Ortiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. Ortiz. The network helps show where Ana M. Ortiz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana M. Ortiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 4 | |
| 3 | 2019 | 5 | |
| 4 | Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis. | 2018 | 38 |
| 5 | 2018 | 6 | |
| 6 | 2018 | 11 | |
| 7 | 2017 | 29 | |
| 8 | 2017 | 18 | |
| 9 | 2016 | 31 | |
| 10 | 2015 | 72 | |
| 11 | 2014 | 22 | |
| 12 | 2014 | 33 | |
| 13 | 2013 | 23 | |
| 14 | 2013 | 23 | |
| 15 | 2013 | 13 | |
| 16 | 2012 | 17 | |
| 17 | 2012 | 57 | |
| 18 | 2011 | 56 | |
| 19 | 2002 | 22 | |
| 20 | Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15. | 2000 | 8 |
About Ana M. Ortiz
Ana M. Ortiz is a scholar working on Microbiology, Rheumatology and Family Practice, having authored 42 papers that have together received 835 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (13 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Systemic Lupus Erythematosus Research (6 papers), Peripheral Neuropathies and Disorders (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Alzheimer's disease research and treatments (3 papers), Dialysis and Renal Disease Management (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Rheumatology (275 citations), Virology (48 citations) and Hematology (105 citations). Ana M. Ortiz has collaborated with scholars based in Spain, Chile and United States. Frequent co-authors include Juan I. Jorquera, Isidoro González‐Álvaro, Montserrat Costa, Loreto Carmona, Juan J. Gómez‐Reino, Rosario García‐Vicuña, Alejandro Balsa, A Laffón, Rosa P. Gomariz and Giuseppe Melacini.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.